Clinical Trials Directory

Trials / Completed

CompletedNCT01540773

Single Low-Dose of Supplement Amino Acid

Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

Detailed description

Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.

Conditions

Interventions

TypeNameDescription
DRUGAmino acid supplementAn orally administered supplement of the proprietary amino acid derivative
DRUGPlaceboA non-active orally administered supplement of the proprietary amino acid derivative

Timeline

Start date
2011-10-01
Primary completion
2011-12-01
Completion
2012-03-01
First posted
2012-02-29
Last updated
2018-10-22
Results posted
2017-03-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01540773. Inclusion in this directory is not an endorsement.